© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 4, 288-289,
February 16, 2000
© 2000 Oxford University Press
EDITORIALS |
Relation of a Recurrent Intraductal Carcinoma (Ductal Carcinoma In Situ) to the Primary Tumor
Affiliations of authors: E. R. Fisher, National Surgical Adjuvant Breast and Bowel Project (NSABP) Pathology Center, Pittsburgh, PA; B. Fisher, NSABP Scientific Director's Office, Pittsburgh.
Correspondence to: Bernard Fisher, M.D., NSABP Scientific Director's Office, Four Allegheny Center, Suite 602, Pittsburgh, PA 15212-5234 (e-mail: bernard.fisher@nsabp.org).
Chromosomal instability has long been recognized as a feature of malignant neoplasms. In
1975 (1,2), we described quantitative differences in chromosomal
aberrations in premalignant lesions and in methylcholanthrene-induced cancers in rats; in 1978 (3), we noted these differences between women with both premalignant
lesions and breast cancer. The use of digital image analysis of the DNA content of intraductal
carcinomas (ductal carcinoma in situ, or DCIS) and the invasive cancers associated with
them subsequently (4) revealed a close concordance in DNA ploidy and
S-phase content. Although it was tempting to consider our observations as evidence that DCIS
was a precursor of the invasive component, we were uncertain whether similarity in itself was a
reliable indicator of such a pathogenic pathway, since it was possible that an etiologic agent
could have induced the same phenotype in both the large ducts and the ductolobular
REFERENCES